Wegovy ®

DRUG3 trials

Sponsors

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd., Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Leiden University Medical Center

Conditions

Aortic StenosisHeart FailureObesity ControlOverweight or Obesity

Phase 1

The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity

RecruitingNCT06830343

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Overweight or Obesity

Start: 2025-02-27End: 2026-10-01Target: 66Updated: 2026-04-06

Phase 3

Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients

RecruitingNCT07036172

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Obesity Control

Start: 2025-01-03End: 2026-05-31Target: 460Updated: 2025-06-25

Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement

Not yet recruitingNCT07090343

Leiden University Medical CenterAortic Stenosis, Heart Failure

Start: 2026-04-01End: 2031-04-01Target: 826Updated: 2025-07-29